Cargando…

622. The Accessory Genome in Enterococcal Bacteremia: Results from the Vancomycin-Resistant Enterococcal Bacteremia Outcomes Study (VENOUS)

BACKGROUND: Vancomycin-resistant enterococci (VRE) are a major cause of nosocomial bloodstream infections. Enterococci exhibit remarkable genomic plasticity and can recombine through the acquisition of genetic material via mobile genetic elements (MGEs), including resistance genes. The accessory gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simar, Shelby, Hanson, Blake, Contreras, German, Reyes, Katherine, Sahasrabhojane, Pranoti V, Misikir, Helina, Liu, Catherine, Doi, Yohei, Barberis, Fernanda, Abbo, Lilian, Dinh, An Q, Spencer, Maria, Zervos, Marcus, Aitken, Samuel L, van Duin, David, Shelburne, Samuel A, Tran, Truc T, Munita, Jose M, Arias, Cesar A, de los Angeles Spencer, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811187/ http://dx.doi.org/10.1093/ofid/ofz360.690

Ejemplares similares

1009. Venous 1: A Prospective Multicenter Cohort Study of Enterococcal Bacteremia
por: Contreras, German, et al.
Publicado: (2018)

Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I)
por: Contreras, German A, et al.
Publicado: (2021)

2246. Improved Outcomes for Cancer Patients Treated With Ceftazidime–Avibactam vs. Polymyxin-Containing Regimens for Carbapenem-Resistant Enterobacteriaceae Bacteremia
por: Borjan, Jovan, et al.
Publicado: (2019)

1055. Epidemiology and Mechanisms of Carbapenem Resistance in Recurrent Extended-Spectrum β-Lactamase- Producing Enterobacteriaceae Bacteremia
por: Aitken, Samuel L, et al.
Publicado: (2018)

Management of Gram-Positive Bacterial Disease: Staphylococcus aureus, Streptococcal, Pneumococcal and Enterococcal Infections
por: Shelburne, Samuel, et al.
Publicado: (2011)

Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
por: Narayanan, Navaneeth, et al.
Publicado: (2019)

Pharmacokinetic/pharmacodynamic parameters of vancomycin for predicting clinical outcome of enterococcal bacteremia
por: Nham, Eliel, et al.
Publicado: (2022)

Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia
por: Fox, Emily, et al.
Publicado: (2022)

1521. Non-faecium Non-faecalis enterococcal bloodstream infections in patients with cancer
por: Axell-House, Dierdre B, et al.
Publicado: (2022)

60. Creation and Comparison of a Machine Learning Decision Tree and Traditional Risk Score to Predict Ceftriaxone Resistance in Cancer Patients with E. coli Bacteremia
por: Moc, Courtney, et al.
Publicado: (2021)

273. Comparative Effectiveness of Ampicillin in the Treatment of Enterococcus faecalis Bloodstream Infections in Patients With Cancer
por: Sanchez, J P, et al.
Publicado: (2020)

305. Prevalence of Ceftriaxone Susceptible, Piperacillin-tazobactam Non-susceptible Escherichia coli Bacteremia in Patients with Hematologic Malignancy
por: Spitznogle, Sarah L, et al.
Publicado: (2020)

Enterococcal Bacteremia is Associated with Prolonged Stay in the Medical Intensive Care Unit
por: Moses, Viju, et al.
Publicado: (2012)

123. Impact of Enterococcal Bacteremia on Clinical Outcomes in Patients with Liver Cirrhosis
por: Phe, Kady, et al.
Publicado: (2019)

Vancomycin-Nonsusceptible Enterococci Mediated by vanC at a Large Children’s Hospital: Prevalence, Susceptibility, and Impact on Care of Enterococcal Bacteremia
por: Dodson, Daniel S, et al.
Publicado: (2020)

605. Identification of a Novel CMY-Variant Enzyme in a Clinical Escherichia coli Strain with Treatment-Emergent Ceftazidime–Avibactam Resistance
por: Aitken, Samuel L, et al.
Publicado: (2019)

242. Evaluation of PBP4 promoter variation and clinical outcomes in patients with Enterococcus faecalis bacteremia
por: Atterstrom, Rachel, et al.
Publicado: (2023)

Vancomycin-resistant Enterococcal Bacteremia in a Hematology Unit: Molecular Epidemiology and Analysis of Clinical Course
por: Yoo, Jin-Hong, et al.
Publicado: (2005)

Daptomycin versus linezolid for treatment of vancomycin-resistant enterococcal bacteremia: systematic review and meta-analysis
por: Chuang, Yu-Chung, et al.
Publicado: (2014)

Successful treatment of a neonate with persistent vancomycin-resistant enterococcal bacteremia with a daptomycin-containing regimen
por: Beneri, Christy A, et al.
Publicado: (2008)

2682. Prophylaxis-Driven Molecular Epidemiology of Pseudomonas aeruginosa Bloodstream Infections in Adults With Leukemia
por: Endres, Bradley T, et al.
Publicado: (2019)

Comparative Efficacies of Linezolid vs. Tedizolid in an Experimental Murine Model of Vancomycin-Resistant Enterococcal (VRE) Bacteremia
por: Abdelhady, Wessam, et al.
Publicado: (2019)

Clinical Features and Rate of Infective Endocarditis in Non-Faecalis and Non-faecium Enterococcal Bacteremia
por: Jang, Hee-Chang, et al.
Publicado: (2011)

Clinical Outcomes Associated With Linezolid Resistance in Leukemia Patients With Linezolid-Resistant Staphylococcus epidermidis Bacteremia
por: Folan, Stephanie A, et al.
Publicado: (2018)

2674. Microbiome and Cumulative Antibiotic Use as Predictors of Stenotrophomonas maltophilia Infection in Patients with Acute Myeloid Leukemia Receiving Remission-Induction Chemotherapy
por: Aitken, Samuel L, et al.
Publicado: (2019)

Measuring Epidemiologic Effects of Enterococcal Bacteremia and Outcomes From a Nationwide Inpatient Sample Database
por: Cheriyath, Pramil, et al.
Publicado: (2022)

2248. Clinical and Microbiological Outcomes Associated with Real-World Use of Ceftolozane/Tazobactam
por: Cabrera, Nicolo, et al.
Publicado: (2019)

1831. Machine Learning Approaches to Predicting Resistance in Pseudomonas aeruginosa
por: Greenberg, David E, et al.
Publicado: (2019)

Impact of Infectious Diseases Consultation on the Outcome of Patients With Enterococcal Bacteremia: A Systematic Literature Review and Meta-analysis
por: Tholany, Joseph, et al.
Publicado: (2022)

735. Contribution of the Oral Cavity and Gastrointestinal Microbiome on Bloodstream Infections inLeukemia Patients
por: McMahon, Stephanie, et al.
Publicado: (2022)

Post-traumatic vancomycin-resistant enterococcal endophthalmitis
por: Hillier, Roxane J, et al.
Publicado: (2013)

Strengthening of enterococcal biofilms by Esp
por: Spiegelman, Lindsey, et al.
Publicado: (2022)

1643. Pharmacodynamics (PD) of Daptomycin (DAP) in Combination Therapy for Enterococcal Bloodstream Infection (BSI)
por: Avery, Lindsay, et al.
Publicado: (2018)

Identification and Whole Genome Sequencing of the First Case of Kosakonia radicincitans Causing a Human Bloodstream Infection
por: Bhatti, Micah D., et al.
Publicado: (2017)

Antibiotic Stewardship Related to Delayed Diagnosis and Poor Prognosis of Critically Ill Patients with Vancomycin-Resistant Enterococcal Bacteremia: A Retrospective Cohort Study
por: Yang, Mu-Chun, et al.
Publicado: (2022)

Oral and Stool Microbiome Coalescence and Its Association With Antibiotic Exposure in Acute Leukemia Patients
por: Franklin, Samantha, et al.
Publicado: (2022)

185. Does an Infectious Diseases Consultation Improve Clinical Outcomes and Treatment Bundle Adherence for Enterococcal Bacteremia in a Multicenter Healthcare System?
por: Shephard, Emily A, et al.
Publicado: (2021)

Intravitreal linezolid in the management of vancomycin-resistant enterococcal endophthalmitis
por: Babalola, Olufemi Emmanuel
Publicado: (2020)

573. Enterococcal Bacteremia in a Tertiary Care Center in Mexico: A Retrospective Analysis Focus on Vancomycin-Resistant E. faecium and Ampicillin-Resistant E. faecalis
por: Lopez Luis, Bruno A, et al.
Publicado: (2019)

Dual-Site Phosphorylation of the Control of Virulence Regulator Impacts Group A Streptococcal Global Gene Expression and Pathogenesis
por: Horstmann, Nicola, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_774jei26j2nddb8g2mu9682h67